{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:14:17Z","timestamp":1786976057357,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd007479","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T00:00:00Z","timestamp":1399939200000}}],"reference-count":55,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007479.pub2","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T17:31:39Z","timestamp":1400002299000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pericyazine for schizophrenia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Hosam E","family":"Matar","sequence":"first","affiliation":[{"name":"St Helens and Knowsley Hospitals NHS Trust; Department of Trauma and Orthopaedics; Whiston Hospital Prescot Merseyside UK L35 5DR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Qutayba","family":"Almerie","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust; Department of General Surgery; Beckett Street Leeds UK LS9 7TF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Makhoul","sequence":"additional","affiliation":[{"name":"Al Noor Hospitals Group Plc; Airport Road branch; Airport Road Campus P.O. Box 48481 Abu Dhabi United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health University of Nottingham Innovation Park, Triumph Road, Nottingham UK NG7 2TU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Humphreys","sequence":"additional","affiliation":[{"name":"Glyndwr University; Department of Nursing and Health; Mold Road Wrexham UK LL11 2AW"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,13]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD007479.pub2-BIB0001|cit1","first-page":"19","article-title":"A Standard-controlled clinical study with propericiazine in schizophrenic patients","volume":"13","author":"Ananth","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0002|cit2","unstructured":"Grant B Tonks CM The relative value of pericyazine and chlorpromazine in disturbed chronic schizophrenics Proceedings of the Leeds Symposium on Behavioural Disorders 1965 115 20"},{"issue":"8","key":"10.1002\/14651858.CD007479.pub2-BIB0003|cit3","first-page":"873","article-title":"Clinical evaluation of zetopine in chronic schizophrenia: a multi-institutional double blind study in comparison with propericiazine","volume":"9","author":"Iwanaga","year":"1980","journal-title":"Clinical Psychiatry [Seishin Igaku]"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0004|cit4","unstructured":"Leitch A A controlled trial in schizophrenia and allied states with pericyazine Proceedings of the Leeds Symposium on Behavioural Disorder 1965 121 8"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1600-0447.1966.tb08805.x","article-title":"Treatment of disorders of charater and schizophrenia by pericyazine (Neulactil)","volume":"191","author":"Rasch","year":"1966","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD007479.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/070674377201700209","article-title":"Propericiazine in psychiatric emergencies. A controlled comparative study","volume":"17","author":"Ananth","year":"1972","journal-title":"Canadian Psychiatric Association Journal"},{"issue":"519","key":"10.1002\/14651858.CD007479.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1192\/bjp.115.519.169","article-title":"A double blind comparative trial of pericyazine and thioridazine in chronic schizophrenia","volume":"115","author":"Barker","year":"1969","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0008|cit8","unstructured":"Denef P Baro F Van Lommel R Dom R Treatment of chronic psychotic patients with high doses of propericiazine Proceedings of the 5th World Congress of Psychiatry 1971 262 3"},{"issue":"6","key":"10.1002\/14651858.CD007479.pub2-BIB0009|cit9","first-page":"353","article-title":"A clinical study with propericiazine in chronic psychotic patients","volume":"13","author":"Deutsch","year":"1971","journal-title":"Current Therapeutic Research (Clinical and Experimental)"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0010|cit10","unstructured":"Heller GC Mather MD A new phenothiazine in the treatment of psychotic behaviour problems Proceedings of the Leeds Symposium on Behavioural Disorder 1965 80 8"},{"issue":"3","key":"10.1002\/14651858.CD007479.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00427763","article-title":"Prophylactic effect of neuropletics in symptom free schizophrenics - a comparative dose-response study of haloperidol and propericiazine","volume":"82","author":"Nishikawa","year":"1984","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD007479.pub2-BIB0012|cit12","first-page":"526","article-title":"Clinical studies with propericiazine","volume":"28","author":"Jean","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1192\/bjp.114.506.111","article-title":"The use of pericyazine and chlorpromazine with disturbed mentally subnormal patients","volume":"114","author":"Weir","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.1.5536.352","article-title":"Pericyazine","volume":"1","author":"Anonymous","year":"1967","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0016|cit16","unstructured":"Astrup C Clemm F Clinical and experimental studies of pericyazine in schizophrenic patients Proceedings of the Leeds Symposium on Behavioural Disorders Leeds 1965 144 50"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0017|cit17","unstructured":"Ban TA Human pharmacology and systematic clinical studies with a new phenothiazine Proceedings of the Leeds Symposium on Behavioural Disorders 1965 240 53"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0018|cit18","unstructured":"Bartlet E Study of a new phenothiazine in chronic schizophrenia Proceedings of the Leeds Symposium on Behavioural Disorders 1965 164 9"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0019|cit19","first-page":"925","article-title":"Propericiazine: effectiveness against hostility and aggression as compared to chlorpromazine","volume":"29","author":"Becker","year":"1981","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0021|cit21","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2008"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0022|cit22","unstructured":"Boardman RH Maintenance therapy with pericyazine in chronic psychoses Proceedings of the Leeds Symposium on Behavioural Disorders Leeds 1965 151 2"},{"issue":"4","key":"10.1002\/14651858.CD007479.pub2-BIB0023|cit23","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0025|cit25","unstructured":"Chanoit P Deshaies G Mignot P Une indication particuliere du 8909 R.P: Les troubles du caractere Comptes rendus du congres de psychiatrie et de neurologie de langue Francaise 1962 430 62"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0026|cit26","first-page":"339","article-title":"Etude clinique d'un nouveau neuroleptiquc: Le pericyazine","volume":"71","author":"Chanoit","year":"1964","journal-title":"Presse M\u00e9dicale"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0027|cit27","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa 2000"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0028|cit28","first-page":"602","article-title":"The clinical effects of RP-8909","volume":"51","author":"Deshaies","year":"1962","journal-title":"Enccphalc"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal Epidemiology"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0033|cit33","volume-title":"Psychiatric Mental Health Nursing","author":"Fortinash","year":"2000"},{"issue":"7","key":"10.1002\/14651858.CD007479.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0035|cit35","unstructured":"Grant B Tonks CM The relative value of pericyazine and chlorpromazine in disturbed chronic schizophrenics Proceedings of the Leeds Symposium on Behavioural Disorders Leeds 1965 114 20"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0038|cit38","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]The Cochrane Collaboration, 2005 Cochrane Handbook for Systematic Reviews of Interventions 2005"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0039|cit39","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006] The Cochrane Collaboration, 2006 Cochrane Handbook for Systematic Reviews of Interventions 2006"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0040|cit40","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org."},{"issue":"1","key":"10.1002\/14651858.CD007479.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2009.07707.x","article-title":"Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials","volume":"146","author":"Hutton","year":"2009","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD007479.pub2-BIB0042|cit42","first-page":"796","article-title":"Pericyazine in clinical practice","volume":"41","author":"Jenner","year":"1970","journal-title":"Laval Medical"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0043|cit43","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"2-3","key":"10.1002\/14651858.CD007479.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"15","key":"10.1002\/14651858.CD007479.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD007479.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0006-3223(89)90265-5","article-title":"Prophylactic effects of neuroleptics in symptom-free schizophrenics: a comparative dose-response study of timiperone and sulpiride","volume":"25","author":"Nishikawa","year":"1989","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0091-3057(95)02110-8","article-title":"Modulation of plus-maze behaviour in mice by preferential D3-receptor agonist 7-OH-DPAT","volume":"54","author":"Rodgers","year":"1996","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0051|cit51","volume-title":"Modern Psychmetrics","author":"Rust","year":"1989"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007479.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD007479.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"7","key":"10.1002\/14651858.CD007479.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007479.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T15:03:03Z","timestamp":1713366183000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007479.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,13]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007479.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,13]]}}}